Published: Apr, 2017
The global pharmaceutical hot melt extrusion market has been researched to be marked by a very high degree of competition, as per a new analysis made by Transparency Market Research (TMR). With the presence of a telling count of participants into operation, the global pharmaceutical hot melt extrusion market could bear a fragmented landscape.
An intense level of rivalry has been expected to take shape in the foreseeable future as Gabler GmbH & Co. KG, Coperion GmbH, Xtrutech Ltd., Milacron Holdings Corp., and Leistritz AG lead the global pharmaceutical hot melt extrusion market. The report has stated that these players could substantially invest in research and development activities with a view to satisfy consumer demands through innovative products offered in the global pharmaceutical hot melt extrusion market.
TMR has estimated the world pharmaceutical hot melt extrusion market to clinch a rising share of US$36.4 mn by 2024 after recording a US$26.6 mn in 2015. The world pharmaceutical hot melt extrusion market could maintain a 3.90% CAGR during the forecast period. By product, twin screw extruder has been prophesied to reach a par excellence valuation of US$22.94 mn in the pharmaceutical hot melt extrusion market by the concluding forecast year. By geography, the North America pharmaceutical hot melt extrusion market could secure a grander 36.3% share under its belt by the same year.
Pharmaceutical Hot Melt Extrusion Market Exploits Versatility and Shortened Time to Market
The international pharmaceutical hot melt extrusion market has been envisaged to profit from the versatility and spread out future prospectus of the processing technology. Hot melt extrusion can empower agitator designs to become compatible with a specific application via easy optimization. Such unequalled advantages unable to be covered by conventional techniques could smartly fortify the international pharmaceutical hot melt extrusion market.
Industry players have been envisioned to largely benefit with cost-efficient production, speedier formulation development, and uninterrupted operation in the worldwide pharmaceutical hot melt extrusion market. With the emergence of the novel technology in the worldwide pharmaceutical hot melt extrusion market, manufacturers could ensure the efficacy and quality of their products. Low-cost production regions witnessing an influx of outsourced manufacturing activities have also been anticipated to significantly bolster the growth of the worldwide pharmaceutical hot melt extrusion market.
Pharmaceutical Hot Melt Extrusion Market Struggles with Drug/Polymer Stability
The analysts have foretold the possibility of non-compliance to regulatory requirements and quality concerns hindering the growth of the global pharmaceutical hot melt extrusion market. The major drawback of unsuccessful processing of drugs sensitive to higher temperatures could cut short the demand in the global pharmaceutical hot melt extrusion market. Limitation on the part of formulation options due to the properties of active pharmaceutical ingredient (API) and failure to furnish supplies on schedule have been prognosticated to be the other deterrents in the global pharmaceutical hot melt extrusion market.
Nonetheless, specialized API manufacturers could receive a lucrative opportunity and avail deeper penetration into the global pharmaceutical hot melt extrusion market with the advent of novel high potency API (HPAPI). More opportunities have been predicted to birth as healthcare organizations prefer competent contract manufacturing organizations (CMOs) for outsourcing manufacturing services, considering advantages such as best expertise, lean management, cost-effectiveness, and fulfillment of latest technology gap.
The information presented in this review is based on a Transparency Market Research report, titled, “Pharmaceutical Hot Melt Extrusion Market (Product Type - Twin Screw Extruder, Single Screw Extruder, Laboratory Extruder, and RAM Extruder; End User - Research Laboratory, Contract Manufacturing Organization, and Pharma Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
The global pharmaceutical hot melt extrusion market has been segmented as presented below:
- Twin Screw Extruder
- Single Screw Extruder
- Laboratory Extruder
- RAM Extruder
By End User
- Research Laboratory
- Contract Manufacturing Organization
- Pharma Companies
- North America
- Rest of Europe
- Asia Pacific (APAC)
- New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa (MEA)
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453